Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

Secoisolariciresinol diglucoside (Synonyms: LGM2605)

Catalog No. T3415 Copy Product Info
Purity: 99.98%
🥰Excellent
Secoisolariciresinol diglucoside (LGM2605) was cytoprotective in an in vitro model of iron overload-induced redox-inflammatory damage. Secoisolariciresinol diglucoside (25 mg/kg b.w.) exerts the antihyperglycemic effect by preventing the liver from peroxidation damage through inhibition of ROS level mediated increased level of enzymatic and non-enzymatic antioxidants.

Secoisolariciresinol diglucoside

Copy Product Info
🥰Excellent
Catalog No. T3415
Synonyms LGM2605

Secoisolariciresinol diglucoside (LGM2605) was cytoprotective in an in vitro model of iron overload-induced redox-inflammatory damage. Secoisolariciresinol diglucoside (25 mg/kg b.w.) exerts the antihyperglycemic effect by preventing the liver from peroxidation damage through inhibition of ROS level mediated increased level of enzymatic and non-enzymatic antioxidants.

Secoisolariciresinol diglucoside
Cas No. 158932-33-3
Pack SizePriceUSA StockGlobal StockQuantity
5 mg$39In StockIn Stock
10 mg$64In StockIn Stock
25 mg$105In StockIn Stock
50 mg$169In StockIn Stock
100 mg$253In StockIn Stock
500 mg$528-In Stock
For In stock only · Estimated delivery: USA Stock (1-2 days) Global Stock (5-7 days)
Add to Cart
Add to Quotation
For research use only—not for human use. No sales to individuals. Use as intended only.
Questions
TargetMol
View More

Batch Information

Select Batch
Purity:99.98%
Color:White
Contact us for more batch information

Resource Download

Product Introduction

Secoisolariciresinol diglucoside AI Summary
Secoisolariciresinol diglucoside exhibits significant antioxidant activity, as demonstrated through various assays, including reduction of K3FeCN6, DPPH radical scavenging, peroxyl radical scavenging, and hydroxyl radical scavenging activities, with EC50 values indicating high efficiency. It shows comparable antioxidant effects to alpha-tocopherol and ascorbic acid, as well as trolox and gallic acid in specific assays. The compound also displays high stability in HBSS after 48 hours (>95.0%) and very low drug metabolism (<3.0%) in human Caco2 cells over 48 hours. In terms of antiviral properties, Secoisolariciresinol diglucoside inhibits SARS-CoV-2 induced cytotoxicity in Caco-2 and VERO-6 cells at 10 µM concentration after 48 hours, with inhibition rates of -2.73% and -0.11%, respectively. It also inhibits the SARS-CoV-2 3CL-Pro protease by 23.53% at 20 µM concentration, highlighting its potential as an anti-viral agent. Additionally, the compound exhibits inhibitory activity against the human HDAC6 enzyme, with inhibition rates of 29.39% using a commercial peptide substrate and 3.26% with a custom peptide substrate. Overall, Secoisolariciresinol diglucoside presents significant bioactivity as an antioxidant and demonstrates promising anti-viral and enzymatic inhibitory properties..
Note: Summary generated by AI. Data source: ChEMBL
Bioactivity
Description
Secoisolariciresinol diglucoside (LGM2605) was cytoprotective in an in vitro model of iron overload-induced redox-inflammatory damage. Secoisolariciresinol diglucoside (25 mg/kg b.w.) exerts the antihyperglycemic effect by preventing the liver from peroxidation damage through inhibition of ROS level mediated increased level of enzymatic and non-enzymatic antioxidants.
SynonymsLGM2605
Chemical Properties
Molecular Weight686.704
FormulaC32H46O16
Cas No.158932-33-3
SmilesCOc1cc(CC(COC2OC(CO)C(O)C(O)C2O)C(COC2OC(CO)C(O)C(O)C2O)Cc2ccc(O)c(OC)c2)ccc1O
Relative Density.1.52 g/cm3 (Predicted)
Storage & Solubility Information
Storagekeep away from direct sunlight,keep away from moisture | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
Solubility Information
Ethanol: 91.00 mg/mL (132.52 mM), Sonication is recommended.
DMSO: 125.00 mg/mL (182.03 mM), Sonication is recommended.
Pyridine, Methanol: Soluble
H2O: 50.00 mg/mL (72.81 mM), Sonication is recommended.
In Vivo Formulation
10% DMSO+40% PEG300+5% Tween 80+45% Saline: 4.00 mg/mL (5.82 mM), Sonication is recommended.
Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions.
Solution Preparation Table
H2O/Ethanol/DMSO
1mg5mg10mg50mg
1 mM1.4562 mL7.2812 mL14.5623 mL72.8116 mL
5 mM0.2912 mL1.4562 mL2.9125 mL14.5623 mL
10 mM0.1456 mL0.7281 mL1.4562 mL7.2812 mL
20 mM0.0728 mL0.3641 mL0.7281 mL3.6406 mL
50 mM0.0291 mL0.1456 mL0.2912 mL1.4562 mL
Ethanol/DMSO
1mg5mg10mg50mg
100 mM0.0146 mL0.0728 mL0.1456 mL0.7281 mL
Note : The dilution table applies only to solid products. For liquid products, please calculate the stock solution based on the stated concentration and/or density.

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:
TargetMol | Animal experiments For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, TargetMol | Animal experiments and a total of 10 animals are to be administered, using a formulation of TargetMol | reagent 10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH2O , the resulting working solution concentration would be 2 mg/mL.
Stock Solution Preparation:

Dissolve 2 mg of the compound in 100 μL DMSOTargetMol | reagent to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.

Preparation of the In Vivo Formulation:

1) Add 100 μL of the DMSOTargetMol | reagent stock solution to 400 μL PEG300TargetMol | reagent and mix thoroughly until the solution becomes clear.

2) Add 50 μL Tween 80 and mix well until fully clarified.

3) Add 450 μL Saline,PBS or ddH2OTargetMol | reagent and mix thoroughly until a homogeneous solution is obtained.

This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.
All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and Corn oil, are available for purchase on the TargetMol website.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
% Tween 80
% Saline/PBS/ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy Secoisolariciresinol diglucoside | purchase Secoisolariciresinol diglucoside | Secoisolariciresinol diglucoside cost | order Secoisolariciresinol diglucoside | Secoisolariciresinol diglucoside chemical structure | Secoisolariciresinol diglucoside formula | Secoisolariciresinol diglucoside molecular weight